Welcome to LookChem.com Sign In|Join Free
  • or
2-bromo-4-nitro-1-propylbenzene is an organic compound with the molecular formula C9H10BrNO2. It is a derivative of benzene, featuring a bromine atom at the 2nd carbon position, a nitro group at the 4th carbon position, and a propyl chain attached to the 1st carbon position. 2-bromo-4-nitro-1-propylbenzene is characterized by its yellowish color and is soluble in organic solvents. It is primarily used in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals due to its versatile chemical structure. The presence of both electron-withdrawing and electron-donating groups makes it a valuable intermediate in various chemical reactions.

3355-09-7

Post Buying Request

3355-09-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3355-09-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 3355-09-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,3,5 and 5 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 3355-09:
(6*3)+(5*3)+(4*5)+(3*5)+(2*0)+(1*9)=77
77 % 10 = 7
So 3355-09-7 is a valid CAS Registry Number.

3355-09-7Upstream product

3355-09-7Downstream Products

3355-09-7Relevant academic research and scientific papers

CHEMICAL COMPOUNDS

-

Page/Page column 88, (2013/07/05)

The invention is directed to substituted quinoline derivatives. Specifically, the invention is directed to compounds according to Formula (I): wherein R1, R2, R3; R4; and R5 are defined herein. The compounds of the invention are inhibitors of lactate dehydrogenase A and can be useful in the treatment of cancer and diseases associated with tumor cell metabolism, such as cancer, and more specifically cancers of the breast, colon, prostate and lung. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting lactate dehydrogenase A activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 3355-09-7